3173 results for «3459»
3173 results
A randomised study comparing imaging guided implantation of Orsiro and Xience - CASTLE study
20 May 2021 – From EuroPCR 2021
Watch this LBT session, which was originally presented during EuroPCR 2021, to find out more about the CASTLE study, whose aim is to access the results of two types of DES implanted with image guidance in all-comers.
EBC MAIN - the European Bifurcation Club left main coronary bifurcation study
19 May 2021 – From EuroPCR 2021
In this session, originally presented during EuroPCR 2021, discover the EBC Main study and follow the in-depth discussion lead with the PCR clinical research team about the results of this important trial comparing stepwise provisional versus systematic dual stenting strategies.
Best of the European Heart Journal
19 May 2021 – From EuroPCR 2021
Watch this session, originally presented during EuroPCR 2021 by F. Crea, Editor-in-chief, and C. Berry, Executive Editor, to find out more, both about the most cited European Heart Journal original research article, and the most Almetric scored one, and enjoy in-depth analysis of the SOLVE-TAVI and DAEDALUS studies in...
EuroPCR 2021 Hotlines / Late-Breaking Trials: CENTURY JSV, SORT OUT IX, OUTDES, Epic02-RANGO, PIONEER III, and more!
26 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in stents:
- First machine learning derived risk score for target lesion failure
- Ultrathin versus Conventional Second-Generation DES: Meta-Analysis of RCTs
- Five-year outcomes after coronary stenting of small vessels - CENTURY JSV study
- 2-year outcomes of the randomized SORT OUT IX Trial
- Outcomes of...
Shock the Rock: new intravascular lithotripsy real-world data and cases
18 May 2021 – From EuroPCR 2021
Watch this session presented by Emanuele Barbato, Holger Nef, Arif Al Nooryani, Alfonso Ielasi, Michael Haude, Margaret McEntegart and Flavio Luciano Ribichini in order to learn how to optimally adopt Intravascular Lithotripsy (IVL) for treatment of calcified lesions, to identify best practices when using IVL in different clinical settings,...
EuroIntervention - Most cited papers of the year 2020
18 May 2021 – From EuroPCR 2021
Thanks to this session, which was originally presented during EuroPCR 2021, by D. Capodanno, Editor-in-chief, and N. Gonzalo & D. Mylotte, deputy editors, discover the top 3 most cited EuroIntervention Journal papers in 2020, and hear the reaction of the winner, interviewed for the occasion.
EuroPCR 2021: Opening Ceremony - Education & Innovation in Interventional Cardiovascular Medicine
18 May 2021 – From EuroPCR 2021
Did you miss the livestream of EuroPCR 2021’s official Opening Ceremony? Look back to watch the PCR Chairman William Wijns and PCR Vice-Chairman Jean Fajadet launch this innovative edition of the Course. More than ever it was the right place to be!
Tailoring mitral and tricuspid dedicated clip therapies by unlocking their full potential
22 Nov 2021 – From PCR London Valves 2021
Plunge into the universe of mitral and tricuspid in this PCR London Valves 2021 session, and learn how to optimize patient selection and tailor our procedural strategy, understand how to optimize patient outcomes with dedicated devices, and experience how to maximize the use of the G4...
The Navitor with FlexNav TAVI system: when smooth implantability allows to optimise TAVI outcomes
21 Nov 2021 – From PCR London Valves 2021
In this session from the PCR London Valves 2021 Congress, find out more about the new Navitor valve and FlexNav delivery system, discover how to achieve favourable patient outcomes, and learn how choosing a device can impact patient lifetime management.
Obtaining commissural alignment in TAVI
23 Nov 2021 – From PCR London Valves 2021
Watch this session from PCR London Valves 2021 about the importance of commissural alignment in TAVI to know how to achieve commissural alignment with different TAVI systems, and to discover a step-by-step demonstration of patient-specific commissural alignment with the ACURATE neo2 THV system.
PCR London Valves 2021 Hotlines / Late-Breaking Trials: GALILEO, JenaValve TAVI, ENVISAGE TAVI AF, VKA in patients with AF after TAVI
21 Nov 2021 – From PCR London Valves 2021
In this session, find out more about the JenaValve TAVI system in patients with aortic regurgitation, get results from the GALILEO trial, review a late-breaking on-treatment major bleeding analysis from the ENVISAGE TAVI AF trial, and explore the safety and efficacy of edoxaban versus VKA in patients with AF...
Lifetime management of patients with severe aortic stenosis
22 Nov 2021 – From PCR London Valves
Don't miss this PCR London Valves 2021 session if you wish to discuss the importance of lifetime management in patients with severe aortic stenosis, to learn about the latest CoreLab adjudicated outcomes from the Early neo2 registry, and to understand how valve design, implant technique, embolic...
Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform
23 Nov 2021 – From PCR London Valves
Explore the clinical impact of the Edwards portfolio of transcatheter devices for mitral regurgitation treatment in this PCR London Valves 2021 session that you shouldn't miss if you want to attend case-based discussions that will analyze key PASCAL features to treat mitral regurgitation and to participate...
Emergent transcatheter therapy
21 Nov 2021 – From PCR London Valves 2021
This series of 3 videos presented during the PCR London Valves 2021 Congress allows you to appreciate an emergent mitral ViV implantation after a recent re-do bioprosthetic AVR, a cardiogenic shock after transfemoral mitral valve reconstruction, and MitraClip for torrential mitral regurgitation with Impella CP support.
From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options
21 Nov 2021 – From PCR London Valves 2021
Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned. Bernard Prendergast, Philipp Lurz, Fabien Praz and Maurizio Taramasso discuss the challenges and needs regarding mitral and tricuspid valve disease treatment. They also consider what is needed to...
Unusual situations in valvular interventions
21 Nov 2021 – From PCR London Valves 2021
Let's discover an electrosurgical removal of an entrapped central venous catheter, witness a coronary extra-adventitial hematoma complication of transcatheter tricuspid annuloplasty, and appreciate buddy balloon technique as bailout strategy during RVOT stent embolization, among others, in this special PCR London Valves 2021 session dedicated to unusual...
From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options - Part 1 - Best long-term outcomes start with the first procedure
21 Nov 2021 – From PCR London Valves
In this session from PCR London Valve 2021 dedicated to TAVI, mitral, and tricuspid, let's examine the issues related to the lifetime patient journey faced by many patients, starting with an analysis of severe aortic stenosis: how to identify the most important factors when considering the...
Mitra-leaks
21 Nov 2021 – From PCR London Valves 2021
Visualize a complex mitral paravalvular leak, a complex paravalvular leak closure, or a percutaneous closure of a severe paravalvular leak post TMVR-in-MAC in one sole session from the PCR London Valves 2021!
From TAVI to mitral and tricupid - Applying evidence to expand patients' treatment options - Part 2 - Securing long-term patient options
22 Nov 2021 – From PCR London Valves
Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned, as you can notice in this session broadcast at PCR London Valves 2021 Congress, focusing on this topic area. Watch it now if you wish to understand how key...
Innovation and imaging guidance for tricuspid valve replacement
21 Nov 2021 – From PCR London Valves
Watch this TNT session broadcast at PCR London Valves 2021 Congress to learn more about the crucial importance of understanding imaging and having high-quality imaging to guide transcatheter tricuspid valve intervention.
